A skin biostimulator aims to reverse sun damage without the peel downtime

NCT ID NCT07722351

First seen Jul 23, 2026 · Last updated Jul 24, 2026 · Updated 1 time

Summary

This trial tests whether a topical chemical skin biostimulator containing homocysteic acid can improve firmness, wrinkles, texture, and hydration in women aged 39–69 with sun-damaged skin. Twenty-five women receive four treatment sessions two weeks apart, followed by a home-care routine. Researchers measure skin changes before treatment and at 2 and 12 weeks after the series to see if the biostimulator produces lasting improvement without the downtime of traditional chemical peels.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
a topical chemical skin biostimulator containing ammonium trichloroacetate, homocysteic acid, phytic acid, and citric acid (PRX plus)
What this could lead to
If it works, this could offer a non-invasive option to improve skin firmness, reduce wrinkles, and even out skin tone in aging skin with minimal recovery time.
What could go wrong
This is a small, early study with only 25 women, so results may not apply broadly. The treatment may cause irritation or fail to produce lasting improvements.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HYPERPIGMENTATION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Hyperpigmentation hyperpigmentation of the skin Melanosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Department of Practical Cosmetology and Skin Diagnostics, Faculty of Pharmaceutical Sciences in Sosnowiec, Medical University of Silesia in Katowice

    Sosnowiec, Poland

More trials for these conditions

Other studies related to the condition(s) this trial covers.